- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/66 - One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulfur, or nitrogen atom, e.g. pyridoxal
Patent holdings for IPC class C07D 213/66
Total number of patents in this class: 24
10-year publication summary
|
0
|
2
|
1
|
3
|
0
|
1
|
3
|
0
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1793 |
4 |
| Calico Life Sciences LLC | 94 |
4 |
| Cellix Bio Private Limited | 51 |
2 |
| Celagenex Research (India) PVT. LTD. | 56 |
2 |
| Henkel AG & Co. KGaA | 10419 |
1 |
| Albireo AB | 168 |
1 |
| Gwangju Institute of Science and Technology | 744 |
1 |
| Indigene Pharmaceuticals, Inc. | 9 |
1 |
| Shin Poong Pharmaceutical Co., Ltd. | 40 |
1 |
| Tokai University Educational System | 166 |
1 |
| Zhejiang Nhu Company Limited | 170 |
1 |
| Geneheal Biotechnology Co., Ltd. | 31 |
1 |
| Link Technologies Limited | 1 |
1 |
| Shandong Nhu Fine Chemical Science and Technology Company Ltd. | 16 |
1 |
| Alexander Shulgin Research Institute, Inc. | 15 |
1 |
| Lamacics Co., Ltd. | 1 |
1 |
| Other owners | 0 |